Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes

Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes

Ex vivo transduction of human CD34+ hematopoietic stem/progenitor cells (hCD34+ HSPCs) and T lymphocytes is a key process that requires high efficiency and low toxicity to achieve effective clinical results. So far, several enhancers have been used to improve this process. Among them, Retronectin hi...

Full description

Bibliographic Details
Main Authors:	Claudia Piovan, Virna Marin, Cinzia Scavullo, Stefano Corna, Erica Giuliani, Sergio Bossi, Anne Galy, David Fenard, Claudio Bordignon, Gian Paolo Rizzardi, Chiara Bovolenta
Format:	Article
Language:	English
Published:	Elsevier 2017-06-01
Series:	Molecular Therapy: Methods & Clinical Development
Subjects:	lentiviral vector transduction HSC T lymphocytes additive peptide
Online Access:	http://www.sciencedirect.com/science/article/pii/S2329050117300438

Similar Items

RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope
by: Virna Marin, et al.
Published: (2016-01-01)

Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy
by: Alejandra Gutierrez-Guerrero, et al.
Published: (2020-09-01)

Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
by: Alexis Duvergé, et al.
Published: (2020-11-01)

Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?
by: Longfei Deng, et al.
Published: (2023-09-01)

Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease
by: Paul G. Ayoub, et al.
Published: (2024-12-01)

Correction of osteopetrosis in the neonate oc/oc murine model after lentiviral vector gene therapy and non-genotoxic conditioning
by: Sara Penna, et al.
Published: (2024-09-01)

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
by: Inesa Hyseni, et al.
Published: (2020-09-01)

The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
by: Parin Rattananon, et al.
Published: (2021-10-01)

GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice
by: Michela Milani, et al.
Published: (2024-04-01)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
by: Katharine H. D. Crawford, et al.
Published: (2020-05-01)

Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies
by: Francesca Ferrara, et al.
Published: (2021-05-01)

Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral Vectors
by: Mayumi Oakland, et al.
Published: (2013-01-01)

An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
by: K. Grehan, et al.
Published: (2015-01-01)

The Dual-Pseudotyped Lentiviral Vector with VSV-G and Sendai Virus HN Enhances Infection Efficiency through the Synergistic Effect of the Envelope Proteins
by: Bat-Erdene Jargalsaikhan, et al.
Published: (2024-05-01)

Advances of Lentiviral Vectors
by: Fanrong MENG, et al.
Published: (2014-12-01)

Lentiviral delivery of CRISPR Cas9 prime editing system for cystic fibrosis
by: Satyapertiwi, D
Published: (2024)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
by: Rosie J. Munday, et al.
Published: (2022-09-01)

Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing
by: Michelle Yen Tran, et al.
Published: (2022-06-01)

Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes
by: Hélio A. Tomás, et al.
Published: (2019-12-01)

Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing
by: Soledad Banos-Mateos, et al.
Published: (2024-07-01)

Use of Integrase-Minus Lentiviral Vector for Transient Expression
by: Hossein Azadeh, et al.
Published: (2012-01-01)

Lentiviral Vector Bioprocessing
by: Christopher Perry, et al.
Published: (2021-02-01)

The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology
by: Luis Apolonia
Published: (2020-09-01)

Epigenetic control of multiple genes with a lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays
by: Davide Monteferrario, et al.
Published: (2024-06-01)

The Inside Out of Lentiviral Vectors
by: Stéphanie Durand, et al.
Published: (2011-02-01)

Lentiviral-based approach for the validation of cancer therapeutic targets in vivo
by: Chiara Ambrogio, et al.
Published: (2014-10-01)

Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction
by: Audrey Page, et al.
Published: (2020-12-01)

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
by: Alessandra Gallinaro, et al.
Published: (2018-02-01)

Harnessing lentiviral vectors for in vivo gene therapy of liver metastases
by: Giovanna Giacca, et al.
Published: (2024-01-01)

Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges
by: Eduardo Martínez-Molina, et al.
Published: (2020-11-01)

Lentiviral Vectors for Delivery of Gene-Editing Systems Based on CRISPR/Cas: Current State and Perspectives
by: Wendy Dong, et al.
Published: (2021-07-01)

Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors
by: Ane Arrasate, et al.
Published: (2024-10-01)

Off-on polyadenylation strategy as a supplemental mechanism for silencing toxic transgene expression during lentiviral vector production
by: Claude Bagnis, et al.
Published: (2014-06-01)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
by: Negri Donatella RM, et al.
Published: (2012-08-01)

Gene Therapy Applications of Non-Human Lentiviral Vectors
by: Altar M. Munis
Published: (2020-09-01)

Lentiviral vector transduction of spermatozoa as a tool for the study of early development
by: Anil Chandrashekran, et al.
Published: (2014-01-01)

Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment
by: Diana Zala, et al.
Published: (2005-12-01)

Production of Lentiviral Vectors Using Suspension Cells Grown in Serum-free Media
by: Matthew Bauler, et al.
Published: (2020-06-01)

Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury
by: Ciara Shortiss, et al.
Published: (2021-08-01)

Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer
by: Nicole Cordes, et al.
Published: (2022-09-01)